Published in J Immunol Res on December 26, 2016
European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr (2012) 10.61
Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med (2003) 7.80
Risk of pediatric celiac disease according to HLA haplotype and country. N Engl J Med (2014) 5.44
Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease. JAMA (2005) 3.61
Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther (2007) 3.53
The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology (2005) 3.33
Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY). Diabetologia (1996) 3.23
Type 1 diabetes through the life span: a position statement of the American Diabetes Association. Diabetes Care (2014) 2.75
The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants. Pediatr Diabetes (2011) 2.44
AGA Institute Medical Position Statement on the Diagnosis and Management of Celiac Disease. Gastroenterology (2006) 1.94
A report on the International Transglutaminase Autoantibody Workshop for Celiac Disease. Am J Gastroenterol (2009) 1.94
Natural history of celiac disease autoimmunity in a USA cohort followed since 1974. Ann Med (2010) 1.91
Celiac disease revealed in 3% of Swedish 12-year-olds born during an epidemic. J Pediatr Gastroenterol Nutr (2009) 1.79
Histopathology of celiac disease. Biomed Pharmacother (2000) 1.79
Usefulness of symptoms to screen for celiac disease. Pediatrics (2014) 1.75
One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies. J Autoimmun (1999) 1.62
Distinguishing persistent insulin autoantibodies with differential risk: nonradioactive bivalent proinsulin/insulin autoantibody assay. Diabetes (2011) 1.53
GAD65 autoantibodies detected by electrochemiluminescence assay identify high risk for type 1 diabetes. Diabetes (2013) 1.19
Increasing prevalence of coeliac disease in Denmark: a linkage study combining national registries. Acta Paediatr (2011) 1.15
Need for quantitative assessment of transglutaminase autoantibodies for celiac disease in screening-identified children. J Pediatr (2005) 1.14
Proinsulin/Insulin autoantibodies measured with electrochemiluminescent assay are the earliest indicator of prediabetic islet autoimmunity. Diabetes Care (2013) 1.11
Electrochemiluminescence assays for insulin and glutamic acid decarboxylase autoantibodies improve prediction of type 1 diabetes risk. Diabetes Technol Ther (2015) 0.97
An electrochemical immunoassay for the screening of celiac disease in saliva samples. Anal Bioanal Chem (2015) 0.79
Challenges in diagnosing type 1 diabetes in different populations. Diabetes Metab J (2012) 0.91
Characteristics of maturity onset diabetes of the young in a large diabetes center. Pediatr Diabetes (2015) 0.86
Exploring T cell reactivity to gliadin in young children with newly diagnosed celiac disease. Autoimmune Dis (2014) 0.75
Plasma 25-Hydroxyvitamin D Concentration and Risk of Islet Autoimmunity. Diabetes (2017) 0.75